Mountain View
Medical News Today
Semaglutide boosts heart health, weight loss but may lead to gut problems
A new meta-analysis confirms that semaglutide drugs like Ozempic are not only effective for weight loss, but can also protect the heart. However, certain doses and delivery systems can lead to side effects affecting the gut.
Tenecteplase more likely to lead to 'excellent' stroke recovery, study finds
A recent paper reports that the use of the drug tenecteplase, not yet approved for stroke treatment in the U.S., may lead to slightly better outcomes after a stroke than the commonly used alteplase.
Medical News Today
995+
Posts
11M+
Views
As an organization, MNT strives for a deeper understanding of health. Medical News Today is one of the fastest growing health information sites in the United States. Every month, more than 85 million people* from across the globe come to Medical News Today for our in-depth health information and the latest news in medical research. Our journalists get under the skin of health and medicine. We believe that knowledge enables the pursuit of good health and well-being. Using peer reviewed studies, medical experts, and reputable sources, our passionate and curious team of writers and editors unravels the complexities of medical research and science, breaking it down to give you clear, objective, and accurate health information. Our content is science-led, facts-first, inquisitive, and always approachable. Through our content, we hope to inspire you to seek new knowledge, ask questions, and take healthy actions. We want you to feel confident in owning your health journey and making informed decisions for yourself and your loved ones. We aim to empower our readers to live their strongest, healthiest lives. Stay up to date with the latest health news and information by subscribing to our newsletter or following Medical News Today.
It’s essential to note our commitment to transparency:
Our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies. As a platform hosting over 100,000 pieces of content published daily, we cannot pre-vet content, but we strive to foster a dynamic environment for free expression and robust discourse through safety guardrails of human and AI moderation.